RxDino, LLC

RxDino, LLC is a Cincinnati, Ohio-based pharmaceutical company focused on the development of advanced corticosteroid formulations. Its primary product, ZCort Ultra+, is a patented, next-generation over-the-counter hydrocortisone acetate 1% cream. The formulation is distinct due to its inclusion of dehydroepiandrosterone (DHEA), vitamin E, and a blend of botanicals, which are designed to enhance the efficacy of hydrocortisone while helping to prevent skin thinning, a common side effect associated with topical corticosteroids.

The product is intended to treat a variety of skin conditions and irritations, including eczema, psoriasis, seborrheic dermatitis, poison ivy, insect bites, and various forms of itching. The company has conducted clinical research to validate its technology, including a double-blind two-week trial in chronic eczema where it reportedly outperformed the market-leading hydrocortisone brand, as well as an 8-week irritation and sensitization study. RxDino’s products are aimed at consumers seeking relief from skin inflammation and are available through major retail channels such as Amazon and Walmart.com.